There are several types of GLP medications that engage different types of glucagon receptors, giving them different effects in different people: Single receptor agonists (GLP-1 only): Ozempic, Wegovy, Saxenda Dual receptor agonists (GLP-1 + GIP): Mounjaro, Zepbound Triple receptor agonists (GLP-1 + GIP + glucagon): in development early studies show even greater metabolic effects These medications are changing how we are able to ameliorate obesity, food addiction, insulin resistance, and cardiometabolic risks
Safety and Potential Risks When prescribed by a qualified health care provider, peptide-based medications are generally safe and widely used in approved pharmaceuticals, vaccines, and supplements
Within the ER, the signal peptide is cleaved, disulfide bonds form, and the peptide is folded
Effects of semaglutide on asthma control and quality of life in obese patients: A double-blind, placebo-controlled study
We've had an obesity epidemic in the country as a whole, but it's worse among the mentally ill (Goldberg, 2023)